VASTHERA
Latest round
- Series B
Last raised
- Mar 2022
Total raised
- $20M
Investors
- 9
About VASTHERA
Based in Seoul, South Korea, and founded in 2018 by its CEO, SangWon Kang, and COO, YongSoon Ahn, VASTHERA operates as a biotechnology company that specializes in synthetic therapeutics targeting vascular hyperplasia. As of March 2022, the company has a team of four people. VASTHERA offers a platform technology for the peroxide-based redox signaling network. The company develops MOA drugs targeting arterial diseases including pulmonary arterial hypertension, a form of pulmonary hypertension, in-stent restenosis, angina, and cardiac infarction, which occur when blood flow decreases or stops to a part of the heart due to the rupture of coronary arterial vessels, causing damage to the heart muscle, atherosclerosis, a disease in which the inside of an artery narrows due to the build-up of plaque, and heart failure, when the heart is unable to pump sufficiently to maintain blood flow to meet the body's needs.
Who invested in VASTHERA
9 investors across 2 rounds
See all investors in VASTHERA
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about VASTHERA
Who invested in VASTHERA?
VASTHERA has 9 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has VASTHERA raised?
VASTHERA has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did VASTHERA last raise money?
VASTHERA's most recent round on record is a Series B, in Mar 2022.
What does VASTHERA do?
Based in Seoul, South Korea, and founded in 2018 by its CEO, SangWon Kang, and COO, YongSoon Ahn, VASTHERA operates as a biotechnology company that specializes in synthetic therapeutics targeting vascular hyperplasia.
Where is VASTHERA headquartered?
VASTHERA is headquartered in Seoul, South Korea.
Which VCs invest in companies like VASTHERA?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at VASTHERA's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like VASTHERA? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.